​

Funding Round

Private Equity Round - 3D Medicines

Private Equity Round - 3D Medicines

Investment Firm

Overview

3D Medicines mission is to improve people’s health through cancer personalized diagnostics and treatment.

Announced Date

Oct 19, 2020

Funding Type

Private Equity

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

CPE

CPE

CPE is a early_stage_venture and late_stage_venture and private_equity firm.

Participant Investors

5

Investor Name
Participant InvestorLucion
Participant InvestorCPE
Participant InvestorShanghai Pudong Science and Technology Investment
Participant InvestorHaier
Participant InvestorTsing Capital

Round Details and Background

3D Medicines raised $224476969 on 2020-10-19 in Private Equity Round

3D Medicines mission is to improve people’s health through cancer personalized diagnostics and treatment.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 06, 2020
Venture Round - 3D Medicines
6-40.1M
Oct 19, 2020
Private Equity Round - 3D Medicines
11-224.5M
Oct 09, 2020
Venture Round - 3D Medicines
7-140.0M
Nov 01, 2020
Series D - 3D Medicines
5-undefined

Recent Activity

There is no recent news or activity for this profile.